Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
Anantharaman A, Friedlander T, Lu D, Krupa R, Premasekharan G, Hough J, Edwards M, Paz R, Lindquist K, Graf R, Jendrisak A, Louw J, Dugan L, Baird S, Wang Y, Dittamore R, Paris PL.
Anantharaman A, et al. Among authors: baird s.
BMC Cancer. 2016 Sep 22;16(1):744. doi: 10.1186/s12885-016-2758-3.
BMC Cancer. 2016.
PMID: 27658492
Free PMC article.